AT
The startup develops biopharmaceuticals through in-licensing and co-development, focusing on anti-inflammatory, anti-bacterial, and anti-infective medicines targeting resistant microorganisms. By addressing the growing issue of antibiotic resistance, the company enables healthcare professionals to effectively treat infections that are difficult to manage with existing therapies.
Updated 18 months ago
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ON
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops biopharmaceuticals through in-licensing and co-development, focusing on anti-inflammatory, anti-bacterial, and anti-infective medicines targeting resistant microorganisms. By addressing the growing issue of antibiotic resistance, the company enables healthcare professionals to effectively treat infections that are difficult to manage with existing therapies.